PROTECTOR FORSIKRG And ARCTICZYMES TECHNO On The List Of Winners And Losers Of Thursday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are PROTECTOR FORSIKRG, FERMENTALG, and NYXOAH.

Financial Asset Price Change Updated (EST)
PROTECTOR FORSIKRG (PROT.OL) 218.00 15.59% 2024-02-01 12:42:24
FERMENTALG (FALG.PA) 0.63 10.16% 2024-02-01 13:03:23
NYXOAH (NYXH.BR) 9.34 8.6% 2024-02-01 12:20:54
MYHOTELMATCH (MHM.PA) 0.77 8.13% 2024-02-01 13:20:30
BEAULIEU-AV. CERT (BEAB.BR) 1.22 7.02% 2024-02-01 12:05:00
KAUFMAN ET BROAD (KOF.PA) 29.30 6.74% 2024-02-01 13:05:21
JINHUI SHIPP TRANS (JIN.OL) 7.04 6.67% 2024-02-01 12:40:40
AKER HORIZONS (AKH.OL) 4.68 5.5% 2024-02-01 12:24:25
BIOTALYS (BTLS.BR) 4.16 5.32% 2024-02-01 12:05:12
NORBIT (NORBT.OL) 61.80 4.75% 2024-02-01 12:41:25

The three biggest losers today are ARCTICZYMES TECHNO, BIOSENIC, and DASSAULT SYSTEMES.

Financial Asset Price Change Updated (EST)
ARCTICZYMES TECHNO (AZT.OL) 34.95 -13.38% 2024-02-01 12:24:34
BIOSENIC (BIOS.BR) 0.04 -12.17% 2024-02-01 12:05:11
DASSAULT SYSTEMES (DSY.PA) 42.91 -11.04% 2024-02-01 13:02:02
GRAINES VOLTZ (GRVO.PA) 26.15 -10.29% 2024-02-01 13:04:23
VOLTALIA (VLTSA.PA) 7.32 -8.04% 2024-02-01 13:24:42
PROSAFE (PRS.OL) 57.20 -7.74% 2024-02-01 12:42:22
ADOCIA (ADOC.PA) 10.74 -7.57% 2024-02-01 12:44:53
MOLTEN VENTURES (GRW.IR) 2.88 -7.1% 2024-02-01 12:22:48
QUESTERRE ENERGY (QEC.OL) 1.85 -6.84% 2024-02-01 12:42:27
ING GROEP N.V. (INGA.AS) 12.31 -6.7% 2024-02-01 12:02:28

Winners today

1. PROTECTOR FORSIKRG (PROT.OL)

15.59% Price Change

Protector Forsikring ASA, a general insurance company, provides various insurance products to the commercial and public sectors, and the affinity insurance markets in Norway, Denmark, Sweden, the United Kingdom, and Finland. It operates in Commercial Lines of Business and Public Lines of Business segments. The company offers personal, motor, property, liability, and change of ownership insurance. It sells its products to non-marine industries through insurance brokers. Protector Forsikring ASA was founded in 2003 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PROTECTOR FORSIKRG jumping 15.59% to €218.00 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.08% to €1,279.30, after three consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, PROTECTOR FORSIKRG has a trailing twelve months EPS of kr10.66.

PE Ratio

PROTECTOR FORSIKRG has a trailing twelve months price to earnings ratio of 20.45. Meaning, the purchaser of the share is investing kr20.45 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.4%.

Moving Average

PROTECTOR FORSIKRG’s worth is way higher than its 50-day moving average of kr183.87 and way higher than its 200-day moving average of kr170.70.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 46.6% and a negative 61.3%, respectively.

Sales Growth

PROTECTOR FORSIKRG’s sales growth for the current quarter is 15.2%.

More news about PROTECTOR FORSIKRG.

2. FERMENTALG (FALG.PA)

10.16% Price Change

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.

CAC 40 ended the session with FERMENTALG rising 10.16% to €0.63 on Thursday while CAC 40 slid 0.89% to €7,588.75.

Earnings Per Share

As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.52%.

Moving Average

FERMENTALG’s worth is way above its 50-day moving average of €0.50 and way below its 200-day moving average of €0.90.

More news about FERMENTALG.

3. NYXOAH (NYXH.BR)

8.6% Price Change

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with NYXOAH rising 8.6% to €9.34 on Thursday while BEL 20 fell 1.08% to €3,623.30.

Earnings Per Share

As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.76%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NYXOAH’s EBITDA is -13.74.

More news about NYXOAH.

4. MYHOTELMATCH (MHM.PA)

8.13% Price Change

MyHotelMatch S.A. engages in the development of an online hotel reservation platform based on Artificial Intelligence (AI). It operates as an online travel agency based on the principle of online dating. MyHotelMatch S.A. was incorporated in 2010 and is headquartered in Biot, France.

CAC 40 ended the session with MYHOTELMATCH rising 8.13% to €0.77 on Thursday, after three consecutive sessions in a row of losses. CAC 40 fell 0.89% to €7,588.75, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, MYHOTELMATCH has a trailing twelve months EPS of €-1.13.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MYHOTELMATCH’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

MYHOTELMATCH’s stock is valued at €0.77 at 21:40 EST, below its 52-week low of €0.79.

Volatility

MYHOTELMATCH’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.09%, a negative 1.46%, and a positive 2.74%.

MYHOTELMATCH’s highest amplitude of average volatility was 6.20% (last week), 2.84% (last month), and 2.74% (last quarter).

Moving Average

MYHOTELMATCH’s value is way below its 50-day moving average of €0.90 and way under its 200-day moving average of €1.71.

More news about MYHOTELMATCH.

5. BEAULIEU-AV. CERT (BEAB.BR)

7.02% Price Change

Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with BEAULIEU-AV. CERT rising 7.02% to €1.22 on Thursday while BEL 20 slid 1.08% to €3,623.30.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BEAULIEU-AV. CERT’s stock is considered to be overbought (>=80).

More news about BEAULIEU-AV. CERT.

6. KAUFMAN ET BROAD (KOF.PA)

6.74% Price Change

Kaufman & Broad S.A. operates as a property developer and builder in France. It designs, develops, builds, and sells single-family homes in communities, managed residences, offices, shops, hotels, and logistics platforms and business parks. The company was founded in 1968 and is headquartered in Courbevoie, France.

CAC 40 ended the session with KAUFMAN ET BROAD rising 6.74% to €29.30 on Thursday while CAC 40 slid 0.89% to €7,588.75.

Earnings Per Share

As for profitability, KAUFMAN ET BROAD has a trailing twelve months EPS of €2.99.

PE Ratio

KAUFMAN ET BROAD has a trailing twelve months price to earnings ratio of 9.8. Meaning, the purchaser of the share is investing €9.8 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.32%.

Volatility

KAUFMAN ET BROAD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.57%, a negative 0.47%, and a positive 1.39%.

KAUFMAN ET BROAD’s highest amplitude of average volatility was 2.34% (last week), 1.27% (last month), and 1.39% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

KAUFMAN ET BROAD’s EBITDA is 0.19.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 2.4 and the estimated forward annual dividend yield is 9.5%.

More news about KAUFMAN ET BROAD.

7. JINHUI SHIPP TRANS (JIN.OL)

6.67% Price Change

Jinhui Shipping and Transportation Limited, an investment holding company, engages in ship chartering and owning activities internationally. The company provides ship management and shipping agent services, as well as engages in the money lending and property investment activities. It also owns a fleet of twenty four grabs fitted supramaxes and one chartered-in-panamax. The company was founded in 1987 and is based in Hong Kong, Hong Kong. Jinhui Shipping and Transportation Limited operates as a subsidiary of Jinhui Holdings Company Limited.

Oslo Børs Benchmark Index_GI ended the session with JINHUI SHIPP TRANS jumping 6.67% to €7.04 on Thursday while Oslo Børs Benchmark Index_GI rose 0.08% to €1,279.30.

Earnings Per Share

As for profitability, JINHUI SHIPP TRANS has a trailing twelve months EPS of kr-7.07.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.89%.

More news about JINHUI SHIPP TRANS.

8. AKER HORIZONS (AKH.OL)

5.5% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in a portfolio of companies in the renewable energy and green technology comprising private and public companies worldwide. It sources, develops, structures, builds, and operates wind and solar power assets; and develops, builds, owns, and operates clean hydrogen production at industrial scale. The company also provides products, technology, and solutions within the field of carbon capture, utilization, and storage. In addition, it offers products and services to the hydropower industry; designs and delivers superconducting systems; and produces silicon materials. The company was incorporated in 2020 and is headquartered in Lysaker, Norway. Aker Horizons ASA operates as a subsidiary of Aker Capital AS.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS rising 5.5% to €4.68 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.08% to €1,279.30.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-9.91.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Volatility

AKER HORIZONS’s last week, last month’s, and last quarter’s current intraday variation average was 1.04%, 0.09%, and 3.85%.

AKER HORIZONS’s highest amplitude of average volatility was 1.97% (last week), 2.55% (last month), and 3.85% (last quarter).

More news about AKER HORIZONS.

9. BIOTALYS (BTLS.BR)

5.32% Price Change

Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.

BEL 20 ended the session with BIOTALYS jumping 5.32% to €4.16 on Thursday, after five successive sessions in a row of losses. BEL 20 fell 1.08% to €3,623.30, following the last session’s upward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, BIOTALYS has a trailing twelve months EPS of €-0.76.

Volume

Today’s last reported volume for BIOTALYS is 8693 which is 83.62% below its average volume of 53072.

More news about BIOTALYS.

10. NORBIT (NORBT.OL)

4.75% Price Change

Norbit ASA provides technology products and solutions. It operates through Oceans, Connectivity, and Product Innovation and Realization segments. The company offers multibeam sonar systems, including integrated bathymetric systems, bathymetry systems, advanced monitoring systems for dredging, construction and renewables, forward looking wide area imaging, advanced imaging systems for obstacle avoidance/MCM, and above water laser products under the NORBIT WINGHEAD, NORBIT WBMS, NORBIT NORdredge, and NORBIT FLS names; customized cable assemblies, electromechanical box builds, and operational solutions; SeaCOP, a sensor integration platform and user interface common operational picture for emergency response; SECurus provides thermal and daylight stabilized camera solutions; SeaView, which offers thermal and daylight, pan, tilt, and zoom for environmental monitoring, and security and general surveillance; and SeaDarQ, a radar processing solution. It also provides sensing solutions for detecting threats at sea plus waterside security above and below the surface; FCL600, an underwater light solution for aquaculture industry; iData, which offers vehicle monitoring, telematics services, and fleet management for asset and vehicle management; and dedicated short-range communication technology for traffic system and vehicle application. In addition, the company offers research and development services, and contract manufacturing to industrial customers; and sells products based on proprietary technology, including special instrumentation n based on radar, radio frequency, and embedded signal processing technology. The company was founded in 1995 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORBIT jumping 4.75% to €61.80 on Thursday, after three sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.08% to €1,279.30, after three consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, NORBIT has a trailing twelve months EPS of kr3.07.

PE Ratio

NORBIT has a trailing twelve months price to earnings ratio of 20.13. Meaning, the purchaser of the share is investing kr20.13 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.08%.

Yearly Top and Bottom Value

NORBIT’s stock is valued at kr61.80 at 21:40 EST, under its 52-week high of kr67.00 and way above its 52-week low of kr30.40.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORBIT’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 3% and a drop 9.1% for the next.

More news about NORBIT.

Losers Today

1. ARCTICZYMES TECHNO (AZT.OL)

-13.38% Price Change

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARCTICZYMES TECHNO falling 13.38% to €34.95 on Thursday while Oslo Børs Benchmark Index_GI rose 0.08% to €1,279.30.

Earnings Per Share

As for profitability, ARCTICZYMES TECHNO has a trailing twelve months EPS of kr0.34.

PE Ratio

ARCTICZYMES TECHNO has a trailing twelve months price to earnings ratio of 102.79. Meaning, the purchaser of the share is investing kr102.79 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.15%.

More news about ARCTICZYMES TECHNO.

2. BIOSENIC (BIOS.BR)

-12.17% Price Change

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with BIOSENIC dropping 12.17% to €0.04 on Thursday while BEL 20 dropped 1.08% to €3,623.30.

Earnings Per Share

As for profitability, BIOSENIC has a trailing twelve months EPS of €7.53.

PE Ratio

BIOSENIC has a trailing twelve months price to earnings ratio of 0.01. Meaning, the purchaser of the share is investing €0.01 for every euro of annual earnings.

Volatility

BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was a positive 4.96%, a negative 1.46%, and a positive 5.95%.

BIOSENIC’s highest amplitude of average volatility was 9.98% (last week), 5.82% (last month), and 5.95% (last quarter).

More news about BIOSENIC.

3. DASSAULT SYSTEMES (DSY.PA)

-11.04% Price Change

Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS design software for mechanical and electronic printed circuit board design solutions, product data management, simulation, manufacturing, and technical communication; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for intersection of natural resources, infrastructure and urban planning; and BIOVIA that develops chemicals, biologics, and materials experiences. The company provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; energy and materials; home and lifestyle; construction, cities, and territories; consumer packaged goods and retail; marine and offshore; and business services. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.

CAC 40 ended the session with DASSAULT SYSTEMES dropping 11.04% to €42.91 on Thursday, following the last session’s downward trend. CAC 40 slid 0.89% to €7,588.75, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, DASSAULT SYSTEMES has a trailing twelve months EPS of €0.78.

PE Ratio

DASSAULT SYSTEMES has a trailing twelve months price to earnings ratio of 55.01. Meaning, the purchaser of the share is investing €55.01 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.44%.

More news about DASSAULT SYSTEMES.

4. GRAINES VOLTZ (GRVO.PA)

-10.29% Price Change

Graines Voltz S.A. engages in the distribution of vegetable and flower seeds, seedlings, and bulbs in France and internationally. It also produces nursery plants. It serves professionals, horticulturists, market gardeners, nurseries, and local authorities. The company was incorporated in 1985 and is headquartered in Colmar, France.

CAC 40 ended the session with GRAINES VOLTZ dropping 10.29% to €26.15 on Thursday while CAC 40 dropped 0.89% to €7,588.75.

Earnings Per Share

As for profitability, GRAINES VOLTZ has a trailing twelve months EPS of €0.35.

PE Ratio

GRAINES VOLTZ has a trailing twelve months price to earnings ratio of 74.71. Meaning, the purchaser of the share is investing €74.71 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.46%.

Volatility

GRAINES VOLTZ’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.74%, a negative 0.01%, and a positive 1.91%.

GRAINES VOLTZ’s highest amplitude of average volatility was 0.97% (last week), 1.29% (last month), and 1.91% (last quarter).

More news about GRAINES VOLTZ.

5. VOLTALIA (VLTSA.PA)

-8.04% Price Change

Voltalia SA engages in the production of electricity from renewable energy sources. It operates through two segments, Energy Sales, and Services. The company develops, constructs, operates, and maintains wind, solar, hydro, biomass, and storage plants. It also develops and sells projects, and procures equipment for solar power plants, as well as provides operations and maintenance services. As of December 31, 2022, the company operated solar power plant with an installed capacity of 49.9 MW. It operates in Africa, the Middle East, Asia, other Europe, Brazil, and Latin America. The company was incorporated in 2005 and is headquartered in Paris, France. Voltalia SA operates as a subsidiary of Voltalia Investissement SA.

CAC 40 ended the session with VOLTALIA sliding 8.04% to €7.32 on Thursday while CAC 40 slid 0.89% to €7,588.75.

Earnings Per Share

As for profitability, VOLTALIA has a trailing twelve months EPS of €0.15.

PE Ratio

VOLTALIA has a trailing twelve months price to earnings ratio of 48.8. Meaning, the purchaser of the share is investing €48.8 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.08%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VOLTALIA’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

VOLTALIA’s stock is valued at €7.32 at 21:40 EST, under its 52-week low of €7.42.

Volume

Today’s last reported volume for VOLTALIA is 326425 which is 257.33% above its average volume of 91351.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 469.86M for the twelve trailing months.

More news about VOLTALIA.

6. PROSAFE (PRS.OL)

-7.74% Price Change

Prosafe SE, together with its subsidiaries, owns and operates semi-submersible accommodation vessels in Brazil, Norway, Trinidad and Tobago, and the United Kingdom. It is also involved in the maintenance and modification of installations on fields for the production, hook-up and commissioning of new fields, tiebacks to existing infrastructure, and decommissioning activities. The company owns and operates a fleet of six semi-submersible accommodation vessels and one tender support vessel. It primarily serves oil and gas industries. The company was founded in 1972 and is headquartered in Stavanger, Norway.

Oslo Børs Benchmark Index_GI ended the session with PROSAFE sliding 7.74% to €57.20 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.08% to €1,279.30.

Earnings Per Share

As for profitability, PROSAFE has a trailing twelve months EPS of kr-56.18.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -213.48%.

Sales Growth

PROSAFE’s sales growth is negative 14.5% for the current quarter and 140.5% for the next.

Moving Average

PROSAFE’s value is below its 50-day moving average of kr61.96 and way under its 200-day moving average of kr96.11.

More news about PROSAFE.

7. ADOCIA (ADOC.PA)

-7.57% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA sliding 7.57% to €10.74 on Thursday, after four successive sessions in a row of gains. CAC 40 fell 0.89% to €7,588.75, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-2.5.

Moving Average

ADOCIA’s worth is way above its 50-day moving average of €9.07 and way above its 200-day moving average of €6.63.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was 2.78%, 0.02%, and 3.40%.

ADOCIA’s highest amplitude of average volatility was 2.78% (last week), 2.90% (last month), and 3.40% (last quarter).

More news about ADOCIA.

8. MOLTEN VENTURES (GRW.IR)

-7.1% Price Change

ISEQ All Share ended the session with MOLTEN VENTURES falling 7.1% to €2.88 on Thursday, following the last session’s downward trend. ISEQ All Share slid 0.61% to €9,121.74, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.34%.

Volatility

MOLTEN VENTURES’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.33%, a negative 0.92%, and a positive 4.82%.

MOLTEN VENTURES’s highest amplitude of average volatility was 0.98% (last week), 2.79% (last month), and 4.82% (last quarter).

Volume

Today’s last reported volume for MOLTEN VENTURES is 174 which is 65.71% above its average volume of 105.

More news about MOLTEN VENTURES.

9. QUESTERRE ENERGY (QEC.OL)

-6.84% Price Change

Questerre Energy Corporation acquires, explores, and develops non-conventional oil and gas projects in Canada. It produces tight oil, oil shale, shale oil, and shale gas. The company primarily holds 40,960 acres located in Kakwa, west central Alberta, including a 25% working interest in 10,080 acres in Kakwa Central; 50% working interest in 4,480 acres in Kakwa North; 50% interest in 22,400 acres in Kakwa West; and 50% interest in 3,840 acres in Kakwa South. It also holds 100% working interest in 11,035 acres located in Antler, Saskatchewan; and oil shale assets in Jordan. The company was formerly known as Westpro Equipment Ltd. and changed its name to Questerre Energy Corporation in December 2000. The company was incorporated in 1971 and is headquartered in Calgary, Canada.

Oslo Børs Benchmark Index_GI ended the session with QUESTERRE ENERGY dropping 6.84% to €1.85 on Thursday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.08% to €1,279.30, after three sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, QUESTERRE ENERGY has a trailing twelve months EPS of kr0.08.

PE Ratio

QUESTERRE ENERGY has a trailing twelve months price to earnings ratio of 23.15. Meaning, the purchaser of the share is investing kr23.15 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.29%.

Yearly Top and Bottom Value

QUESTERRE ENERGY’s stock is valued at kr1.85 at 21:40 EST, way below its 52-week high of kr2.28 and way higher than its 52-week low of kr1.31.

Volume

Today’s last reported volume for QUESTERRE ENERGY is 5417760 which is 148.43% above its average volume of 2180750.

Moving Average

QUESTERRE ENERGY’s value is way above its 50-day moving average of kr1.44 and way higher than its 200-day moving average of kr1.65.

More news about QUESTERRE ENERGY.

10. ING GROEP N.V. (INGA.AS)

-6.7% Price Change

ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with ING GROEP N.V. sliding 6.7% to €12.31 on Thursday, after two consecutive sessions in a row of gains. AEX-Index rose 0.47% to €822.09, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, ING GROEP N.V. has a trailing twelve months EPS of €1.62.

PE Ratio

ING GROEP N.V. has a trailing twelve months price to earnings ratio of 7.6. Meaning, the purchaser of the share is investing €7.6 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.72%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Aug 7, 2023, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 5.33%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 50% and a drop 4.5% for the next.

More news about ING GROEP N.V..

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *